These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 32166622)

  • 1. Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.
    Ramai D; Zakhia K; Fields PJ; Ofosu A; Patel G; Shahnazarian V; Lai JK; Dhaliwal A; Reddy M; Chang S
    Dig Dis Sci; 2021 Feb; 66(2):369-380. PubMed ID: 32166622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis.
    Postigo R; Kim JH
    Infection; 2012 Dec; 40(6):643-8. PubMed ID: 22847629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of fecal microbiota transplant for the treatment of Clostridioides difficile diarrhea: a systematic review and meta-analysis.
    Pomares Bascuñana RÁ; Veses V; Sheth CC
    Lett Appl Microbiol; 2021 Aug; 73(2):149-158. PubMed ID: 33864273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).
    Minkoff NZ; Aslam S; Medina M; Tanner-Smith EE; Zackular JP; Acra S; Nicholson MR; Imdad A
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013871. PubMed ID: 37096495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial.
    Jiang ZD; Jenq RR; Ajami NJ; Petrosino JF; Alexander AA; Ke S; Iqbal T; DuPont AW; Muldrew K; Shi Y; Peterson C; Do KA; DuPont HL
    PLoS One; 2018; 13(11):e0205064. PubMed ID: 30388112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study.
    Youngster I; Sauk J; Pindar C; Wilson RG; Kaplan JL; Smith MB; Alm EJ; Gevers D; Russell GH; Hohmann EL
    Clin Infect Dis; 2014 Jun; 58(11):1515-22. PubMed ID: 24762631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis.
    Hui W; Li T; Liu W; Zhou C; Gao F
    PLoS One; 2019; 14(1):e0210016. PubMed ID: 30673716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes after faecal microbiota transplant by retention enema in both immunocompetent and immunocompromised patients with recurrent Clostridioides difficile infections at an academic medical centre.
    Navalkele BD; Polistico J; Sandhu A; Awali R; Krishna A; Chandramohan S; Tillotson G; Chopra T
    J Hosp Infect; 2020 Dec; 106(4):643-648. PubMed ID: 32991940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
    Pipek B; Valentová H; Fojtík P; Urban O
    Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal Transplants by Colonoscopy and Capsules Are Cost-Effective Strategies for Treating Recurrent Clostridioides difficile Infection.
    Luo Y; Lucas AL; Grinspan AM
    Dig Dis Sci; 2020 Apr; 65(4):1125-1133. PubMed ID: 31493042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection.
    Quraishi MN; Widlak M; Bhala N; Moore D; Price M; Sharma N; Iqbal TH
    Aliment Pharmacol Ther; 2017 Sep; 46(5):479-493. PubMed ID: 28707337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal microbiota transplantation for recurrent Clostridioides difficile infection.
    Haber SL; Raney CRK; Larson TL; Lau JP
    Am J Health Syst Pharm; 2019 Jun; 76(13):935-942. PubMed ID: 31361890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.
    Tixier EN; Verheyen E; Luo Y; Grinspan LT; Du CH; Ungaro RC; Walsh S; Grinspan AM
    Dig Dis Sci; 2022 Mar; 67(3):978-988. PubMed ID: 33748913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Cure Rates in Controlled Trials of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.
    Tariq R; Pardi DS; Bartlett MG; Khanna S
    Clin Infect Dis; 2019 Apr; 68(8):1351-1358. PubMed ID: 30957161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Efficacy of Faecal Microbiota Transplant and Rectal Bacteriotherapy in Patients with Recurrent
    Svensson CK; Cold F; Ribberholt I; Zangenberg M; Mirsepasi-Lauridsen HC; Petersen AM; Helms M
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
    Kelly CR; Khoruts A; Staley C; Sadowsky MJ; Abd M; Alani M; Bakow B; Curran P; McKenney J; Tisch A; Reinert SE; Machan JT; Brandt LJ
    Ann Intern Med; 2016 Nov; 165(9):609-616. PubMed ID: 27547925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
    Luo Y; Tixier EN; Grinspan AM
    Dig Dis Sci; 2020 Dec; 65(12):3647-3651. PubMed ID: 32078714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota transplantation for recurrent Clostridium difficile infection: Experience, protocol, and results.
    Reigadas E; Olmedo M; Valerio M; Vázquez-Cuesta S; Alcalá L; Marín M; Muñoz P; Bouza E
    Rev Esp Quimioter; 2018 Oct; 31(5):411-418. PubMed ID: 30221898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Fecal Microbiota Transplant Capsules Are Safe and Effective for Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.
    Du C; Luo Y; Walsh S; Grinspan A
    J Clin Gastroenterol; 2021 Apr; 55(4):300-308. PubMed ID: 33471490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Vaughn BP; Fischer M; Kelly CR; Allegretti JR; Graiziger C; Thomas J; McClure E; Kabage AJ; Khoruts A
    Clin Gastroenterol Hepatol; 2023 May; 21(5):1330-1337.e2. PubMed ID: 36126907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.